Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breathe Free in Bronchial Asthma
NCT02918487Unknown
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- Dec 2016
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoints: Number of patients with 15% increase in forced expiratory volume (FEV1) from baseline at 6 months and Number of patients with 50 L/min peak expiratory flow rate (PEFR) from baseline at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT02918487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918487.